Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
Dermata to Present at the Emerging Growth Conference on April 3, 2024 [Yahoo! Finance]
Dermata to Present at the Emerging Growth Conference on April 3, 2024
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results [Yahoo! Finance]